Premium
Modular retro‐vectors for transgenic and therapeutic use
Author(s) -
Solaiman Fauzia,
Zink Mary Ann,
Xu Guoping,
Grunkemeyer James,
Cosgrove Dominic,
Saenz Jennifer,
Hodgson Clague P.
Publication year - 2000
Publication title -
molecular reproduction and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.745
H-Index - 105
eISSN - 1098-2795
pISSN - 1040-452X
DOI - 10.1002/(sici)1098-2795(200006)56:2+<309::aid-mrd22>3.0.co;2-y
Subject(s) - biology , vector (molecular biology) , transgene , genetic enhancement , long terminal repeat , computational biology , modular design , viral vector , gene , gene delivery , virology , genetics , computer science , gene expression , recombinant dna , operating system
Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication‐competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno‐retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self‐assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. Mol. Reprod. Dev. 56:309–315, 2000 © 2000 Wiley‐Liss, Inc.